Ischemic heart Disease Market: Roadmap to Win and Drive Customer Value

1. Market Scenario: Ischemic heart disease, also known as Coronary Artery Disease, is a condition that affects the supply of blood to the heart. The blood vessels are narrowed or blocked due to the deposition of cholesterol on their walls. Get Sample Copy for Future Advancements @ https://www.marketresearchfuture.com/sample_request/2585 The prevalence of coronary heart disease is promoted in turn by a high prevalence of cardiovascular risk factors, particularly smoking, hypertension, dyslipidemia, diabetes, and sedentary lifestyles. Countries in Middle East and Africa bear a heavy burden from Ischemic heart disease. According to, Dubai Health Authority, Heart disease is the cause for every 3 in 10 deaths in the UAE. Huge funding in R&D and various initiatives by government are driving the growth for Ischemic heart Disease market in Middle East and Africa. Middle-East and Africa Ischemic heart Disease market is growing steadily. The market is growing at the CAGR of 3.1% and expected to reach to US$ 2.84 billion by 2022. Market Segments: Middle-East and Africa Ischemic heart Disease market has been segmented on the basis of type which comprise stable angina, unstable angina, myocardial infarction, and Others. On the basis of diagnosis the market is segmented into (Electrocardiogram, Echocardiography, Stress Testing, Coronary angiography, Magnetic resonance imaging (MRI), Chest X Ray, and Others. On the basis of treatment type market is segmented into Medications, Surgery, Lifestyle changes, and others. Read Comprehensive Overview of Report @ https://www.marketresearchfuture.com/reports/mea- ischemic-heart-disease-market-2585 Key Players for Middle-East and Africa Ischemic Heart Disease Market: Some of the key players in this market are: King Faisal Specialist Hospital and Research Centre (Saudi Arabia) Riyadh Military Hospital (Saudi Arabia) Hamad Medical Corporation (Qatar) American Hospital Dubai Ganzouri Specialized Hospital (Egypt) AstraZeneca (U.K.) Sanofi (France) Merck Sharp & Dohme Corp. (U.S.) AUM Cardiovascular (US) HeartWare (U.S.)

2. Regional Analysis of Middle-East and Africa Ischemic heart Disease Market: Considering the Middle-East and Africa Ischemic heart Disease Market scenario, UAE region is believed to be the largest market for Middle-East and Africa Ischemic heart Disease. Moreover Saudi Arabia market is also growing and second largest market for Ischemic heart disease. On the other hand, Egypt market is expected to grow at the steady pace in the Middle-East and Africa Ischemic heart Disease during the forecasted period. Rest of the Middle East and Africa region is likely to have a limited but steady growth in the market. For Exclusive Discount Visit @ https://www.marketresearchfuture.com/check-discount/2585 About US: Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Contact Us: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune - 411028 Maharashtra, India Phone: +1 646 845 9312 Email: sales@marketresearchfuture.com